BTI-Biotechnology Institute, 01007 Vitoria, Spain.
University Institute for Regenerative Medicine and Oral Implantology-UIRMI (UPV/EHU-Fundación Eduardo Anitua), 01007 Vitoria, Spain.
Int J Mol Sci. 2023 Jul 7;24(13):11195. doi: 10.3390/ijms241311195.
The present study evaluates the ability of a novel plasma rich in growth factors (PRGF) membrane with improved optical properties to reduce oxidative stress in retinal pigment epithelial cells (ARPE-19 cells) exposed to blue light. PRGF was obtained from three healthy donors and divided into four main groups: (i) PRGF membrane (M-PRGF), (ii) PRGF supernatant (S-PRGF), (iii) platelet-poor plasma (PPP) membrane diluted 50% with S-PRGF (M-PPP 50%), and (iv) M-PPP 50% supernatant (S-PPP 50%). ARPE-19 cells were exposed to blue light and then incubated with the different PRGF-derived formulations or control for 24 and 48 h under blue light exposure. Mitochondrial and cell viability, reactive oxygen species (ROS) production, and heme oxygenase-1 (HO-1) and ZO-1 expression were evaluated. Mitochondrial viability and cell survival were significantly increased after treatment with the different PRGF-derived formulations. ROS synthesis and HO-1 expression were significantly reduced after cell treatment with any of the PRGF-derived formulations. Furthermore, the different PRGF-derived formulations significantly increased ZO-1 expression in ARPE-19 exposed to blue light. The new PRGF membrane with improved optical properties and its supernatant (M-PPP 50% and S-PPP 50%) protected and reversed blue light-induced oxidative stress in ARPE-19 cells at levels like those of a natural PRGF membrane and its supernatant.
本研究评估了一种新型富含生长因子(PRGF)的膜(具有改善的光学性能)减少暴露于蓝光的视网膜色素上皮细胞(ARPE-19 细胞)中氧化应激的能力。从三个健康供体获得 PRGF,并将其分为四个主要组:(i)PRGF 膜(M-PRGF),(ii)PRGF 上清液(S-PRGF),(iii)用 S-PRGF 稀释 50%的血小板贫乏血浆(PPP)膜(M-PPP 50%),以及(iv)M-PPP 50%上清液(S-PPP 50%)。将 ARPE-19 细胞暴露于蓝光下,然后在暴露于蓝光下孵育 24 和 48 小时,并用不同的 PRGF 衍生制剂或对照物孵育。评估线粒体和细胞活力,活性氧(ROS)产生以及血红素加氧酶-1(HO-1)和 ZO-1 表达。在用不同的 PRGF 衍生制剂处理后,线粒体活力和细胞存活率显著增加。在用任何 PRGF 衍生制剂处理细胞后,ROS 合成和 HO-1 表达均显著降低。此外,不同的 PRGF 衍生制剂显著增加了暴露于蓝光的 ARPE-19 中的 ZO-1 表达。具有改善光学性能的新型 PRGF 膜及其上清液(M-PPP 50%和 S-PPP 50%)可保护和逆转 ARPE-19 细胞中的蓝光诱导的氧化应激,其水平与天然 PRGF 膜及其上清液相当。